• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外、离体和体内模型在天疱疮研究中的应用。

In Vitro, Ex Vivo, and In Vivo Models for the Study of Pemphigus.

机构信息

DermoLAB, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Hematology Section, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.

出版信息

Int J Mol Sci. 2022 Jun 24;23(13):7044. doi: 10.3390/ijms23137044.

DOI:10.3390/ijms23137044
PMID:35806044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9266423/
Abstract

Pemphigus is a life-threatening autoimmune disease. Several phenotypic variants are part of this family of bullous disorders. The disease is mainly mediated by pathogenic autoantibodies, but is also directed against two desmosomal adhesion proteins, desmoglein 1 (DSG1) and 3 (DSG3), which are expressed in the skin and mucosae. By binding to their antigens, autoantibodies induce the separation of keratinocytes, in a process known as acantholysis. The two main Pemphigus variants are Pemphigus vulgaris and foliaceus. Several models of Pemphigus have been described: in vitro, ex vivo and in vivo, passive or active mouse models. Although no model is ideal, different models display specific characteristics that are useful for testing different hypotheses regarding the initiation of Pemphigus, or to evaluate the efficacy of experimental therapies. Different disease models also allow us to evaluate the pathogenicity of specific Pemphigus autoantibodies, or to investigate the role of previously not described autoantigens. The aim of this review is to provide an overview of Pemphigus disease models, with the main focus being on active models and their potential to reproduce different disease subgroups, based on the involvement of different autoantigens.

摘要

天疱疮是一种危及生命的自身免疫性疾病。该大疱性疾病家族包含多种表型变异体。这种疾病主要由致病性自身抗体介导,但也针对两种桥粒黏附蛋白,即表皮桥粒芯糖蛋白 1(DSG1)和 3(DSG3),它们在皮肤和黏膜中表达。自身抗体与它们的抗原结合,诱导角质形成细胞分离,这一过程称为棘层松解。天疱疮的两种主要变异体是寻常型天疱疮和落叶型天疱疮。已经描述了几种天疱疮模型:体外、离体和体内,被动或主动小鼠模型。尽管没有一种模型是理想的,但不同的模型显示出特定的特征,这些特征可用于测试关于天疱疮发病机制的不同假设,或评估实验治疗的疗效。不同的疾病模型还使我们能够评估特定天疱疮自身抗体的致病性,或研究以前未描述的自身抗原的作用。本文综述的目的是提供天疱疮疾病模型的概述,主要重点是主动模型及其在基于不同自身抗原参与的情况下重现不同疾病亚组的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/9266423/c9817ccc3a64/ijms-23-07044-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/9266423/5c1880b4cc44/ijms-23-07044-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/9266423/c9817ccc3a64/ijms-23-07044-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/9266423/5c1880b4cc44/ijms-23-07044-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b16e/9266423/c9817ccc3a64/ijms-23-07044-g002.jpg

相似文献

1
In Vitro, Ex Vivo, and In Vivo Models for the Study of Pemphigus.体外、离体和体内模型在天疱疮研究中的应用。
Int J Mol Sci. 2022 Jun 24;23(13):7044. doi: 10.3390/ijms23137044.
2
Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.抗桥粒芯糖蛋白3(寻常型天疱疮抗原)的抗体存在于副肿瘤性天疱疮患者的血清中,并在新生小鼠体内引起棘层松解。
J Clin Invest. 1998 Aug 15;102(4):775-82. doi: 10.1172/JCI3647.
3
Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.寻常型天疱疮:我们对其发病机制认识的最新进展
Minerva Stomatol. 2007 Apr;56(4):215-23.
4
Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.落叶型天疱疮和寻常型天疱疮皮损的临床及显微镜下定位解释。
J Clin Invest. 1999 Feb;103(4):461-8. doi: 10.1172/JCI5252.
5
[Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].[采用酶联免疫吸附测定法(ELISA)检测血清桥粒芯糖蛋白抗体水平以监测寻常型天疱疮患者的疾病活动度]
Beijing Da Xue Xue Bao Yi Xue Ban. 2011 Jun 18;43(3):414-5.
6
Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.免疫吸附法去除寻常型天疱疮 IgG 中的桥粒芯糖蛋白 3 特异性 IgG 可消除其在新生小鼠中的水疱诱导能力。
Front Immunol. 2018 Sep 3;9:1935. doi: 10.3389/fimmu.2018.01935. eCollection 2018.
7
The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient.ADAM10参与寻常型黏膜皮肤类天疱疮中的棘层松解取决于每位患者的自身抗体谱。
Br J Dermatol. 2020 May;182(5):1194-1204. doi: 10.1111/bjd.18382. Epub 2019 Oct 15.
8
A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants.一种针对桥粒芯糖蛋白1和桥粒芯糖蛋白3的新型体内活性天疱疮模型:一种代表所有天疱疮变体的工具。
Biology (Basel). 2023 May 11;12(5):702. doi: 10.3390/biology12050702.
9
The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic.寻常型天疱疮血清中的抗桥粒芯糖蛋白1自身抗体具有致病性。
J Invest Dermatol. 1999 May;112(5):739-43. doi: 10.1046/j.1523-1747.1999.00585.x.
10
Pemphigus, a pathomechanism of acantholysis.天疱疮,一种棘层松解的发病机制。
Australas J Dermatol. 2017 Aug;58(3):171-173. doi: 10.1111/ajd.12562. Epub 2017 Feb 17.

引用本文的文献

1
Desmosomal cadherin tension loss in pemphigus vulgaris mediated by the inhibition of active RhoA at cell-cell adhesions.寻常型天疱疮中桥粒钙黏蛋白张力丧失由细胞间黏附处活性RhoA的抑制介导。
iScience. 2025 Jul 9;28(8):113081. doi: 10.1016/j.isci.2025.113081. eCollection 2025 Aug 15.
2
Desmosomal Cadherin Tension Loss in Pemphigus Vulgaris Mediated by the Inhibition of Active RhoA at Cell-Cell Adhesions.寻常型天疱疮中桥粒钙黏蛋白张力丧失由细胞间黏附处活性RhoA的抑制介导。
bioRxiv. 2024 May 6:2024.05.03.592394. doi: 10.1101/2024.05.03.592394.
3
Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation.

本文引用的文献

1
Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?通过依库珠单抗阻断 FcRn 稳定抗桥粒芯糖蛋白 3 抗体诱导的角质形成细胞单层完整性:天疱疮的新治疗策略?
Cells. 2022 Mar 10;11(6):942. doi: 10.3390/cells11060942.
2
Pitfalls in the Application of Dispase-Based Keratinocyte Dissociation Assay for In Vitro Analysis of Pemphigus Vulgaris.基于Dispase的角质形成细胞解离试验在寻常型天疱疮体外分析中的应用陷阱
Vaccines (Basel). 2022 Jan 28;10(2):208. doi: 10.3390/vaccines10020208.
3
Chronic exposure to the anti-M3 muscarinic acetylcholine receptor autoantibody in pemphigus vulgaris contributes to disease pathophysiology.
他克莫司通过抑制热休克蛋白 27 磷酸化逆转寻常型天疱疮血清诱导的 HaCaT 细胞桥粒芯糖蛋白 1 的缺失。
BMC Immunol. 2023 Nov 8;24(1):43. doi: 10.1186/s12865-023-00582-z.
4
Shedding Light on Skin Autoimmunity: More than Just Skin Deep.揭示皮肤自身免疫:不只是皮肤问题。
Int J Mol Sci. 2023 Jul 28;24(15):12077. doi: 10.3390/ijms241512077.
5
Plasma Exosomal microRNA Profile Reveals miRNA 148a-3p Downregulation in the Mucosal-Dominant Variant of Pemphigus Vulgaris.血浆外泌体 microRNA 谱揭示寻常型天疱疮黏膜优势型中 miRNA 148a-3p 的下调。
Int J Mol Sci. 2023 Jul 15;24(14):11493. doi: 10.3390/ijms241411493.
6
A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants.一种针对桥粒芯糖蛋白1和桥粒芯糖蛋白3的新型体内活性天疱疮模型:一种代表所有天疱疮变体的工具。
Biology (Basel). 2023 May 11;12(5):702. doi: 10.3390/biology12050702.
天疱疮患者慢性暴露于 M3 型乙酰胆碱受体自身抗体导致疾病发病机制。
J Biol Chem. 2022 Mar;298(3):101687. doi: 10.1016/j.jbc.2022.101687. Epub 2022 Feb 7.
4
IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3-Specific B Cell Receptor Knock-in Mouse.IgM 到 IgG 类转换是桥粒芯糖蛋白 3 特异性 B 细胞受体敲入小鼠诱导天疱疮表型所必需的步骤。
J Immunol. 2022 Feb 1;208(3):582-593. doi: 10.4049/jimmunol.2100781. Epub 2022 Jan 7.
5
Intravenous Ig Regulates Anti-Desmoglein 3 IgG Production in B220 Antibody-Producing Cells in Mice with Pemphigus Vulgaris.静脉注射免疫球蛋白可调节寻常型天疱疮小鼠中产生 B220 抗体的细胞中抗桥粒芯糖蛋白 3 IgG 的产生。
J Invest Dermatol. 2022 Jul;142(7):1786-1792.e3. doi: 10.1016/j.jid.2021.11.022. Epub 2021 Nov 27.
6
Human Desmocollin 3‒Specific IgG Antibodies Are Pathogenic in a Humanized HLA Class II Transgenic Mouse Model of Pemphigus.人类桥粒芯胶蛋白 3 特异性 IgG 抗体在类人 HLA II 转基因自身免疫性大疱病小鼠模型中具有致病性。
J Invest Dermatol. 2022 Mar;142(3 Pt B):915-923.e3. doi: 10.1016/j.jid.2021.06.017. Epub 2021 Jul 13.
7
Identification of novel therapeutic targets for blocking acantholysis in pemphigus.寻找用于阻断天疱疮棘层松解的新型治疗靶点。
Br J Pharmacol. 2020 Nov;177(22):5114-5130. doi: 10.1111/bph.15233. Epub 2020 Sep 21.
8
Pemphigus: Current and Future Therapeutic Strategies.天疱疮:当前和未来的治疗策略。
Front Immunol. 2019 Jun 25;10:1418. doi: 10.3389/fimmu.2019.01418. eCollection 2019.
9
Development of a Desmocollin-3 Active Mouse Model Recapitulating Human Atypical Pemphigus.开发一种模拟人类非典型天疱疮的 Desmocollin-3 活性小鼠模型。
Front Immunol. 2019 Jun 19;10:1387. doi: 10.3389/fimmu.2019.01387. eCollection 2019.
10
A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody-induced mucosal blistering in pemphigus.一种新的体外人类口腔黏膜模型显示,抑制p38丝裂原活化蛋白激酶在预防天疱疮中自身抗体诱导的黏膜水疱形成方面无效。
Br J Dermatol. 2020 Apr;182(4):987-994. doi: 10.1111/bjd.18237. Epub 2019 Sep 4.